Safe Harbor Statement Under The Private Securities Litigation Reform Act of 1995: Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. These risks and uncertainties are described in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectation
AIDA PHARMACEUTICALS, INC.
(FORMERLY BAS CONSULTING, INC.) AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS
OF INCOME AND COMPREHENSIVE INCOME
FOR THE THREE MONTHS FOR THE NINE MONTHS
SEPTEMBER 30, SEPTEMBER 30,
2007 2006 2007 2006
REVENUES, (NET) $7,373,770 $7,023,891 $18,687,283 $19,659,235
COST OF GOODS SOLD (3,557,685) (3,103,516) (9,740,952) (9,679,567)
GROSS PROFIT 3,816,085 3,920,375 8,946,331 9,979,668
distribution 1,387,818 1,175,000 3,515,776
|SOURCE Aida Pharmaceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved